Search

Search bills, members, committees and pages...

INDIVIOR

8 federal lobbying filings, 2023 to 2024.

INDIVIOR is a client on 8 federal lobbying filings, 2023 to 2024, reporting $480K across them. Develops, manufactures, and markets pharmaceutical treatments for opioid use disorders Based in Virginia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 it has hired, by filings.

RegistrantFilingsReported
PUTALASTRATEGIES8$480K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20244$240K
20234$240K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues8

Lobbyists

Named on the filings.

LobbyistClientsFilings
CHRISTOPHER PUTALA18

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
INDIVIORPUTALASTRATEGIES2024 fourth_quarter$60KJan 18, 2025
INDIVIORPUTALASTRATEGIES2024 third_quarter$60KOct 19, 2024
INDIVIORPUTALASTRATEGIES2024 second_quarter$60KJul 21, 2024
INDIVIORPUTALASTRATEGIES2024 first_quarter$60KApr 19, 2024
INDIVIORPUTALASTRATEGIES2023 fourth_quarter$60KJan 19, 2024
INDIVIORPUTALASTRATEGIES2023 third_quarter$60KOct 19, 2023
INDIVIORPUTALASTRATEGIES2023 second_quarter$60KJul 19, 2023
INDIVIORPUTALASTRATEGIES2023 first_quarter$60KApr 20, 2023